(VOVWORLD) - 35 volunteers joined phase 2 of the Nano Covax vaccine trials in Hanoi on Thursday. Developed by Nanogen Biotechnology Joint Stock Company, this vaccine is the first in Vietnam to undergo human clinical trials.
 Screening for volunteers participating in registration for the second test of the Nano Covax vaccine |
3 groups of 10 volunteers will be given 3 doses of 25 micrograms, 50 micrograms, or 75 micrograms, and 5 volunteers will be given placebo, an inert substance with no therapeutic value.
The volunteers for phase 2 are 18 to 60 years old, and some have minor background illnesses.
Dr. Do Quyet, Director of Vietnam’s Military Medical Academy, said the results will be reported in May. In phase 3, volunteers will be given only 1 dose.